VEC.L Share News (VEC)

GlaxoSmithKline has signed a worldwide non-exclusive deal with Vectura worth £20m in up front and milestone payments. GSK wants to use some of Vectura's dry powder drug formulation patents in its own respiratory products. The initial payment of £10m is due in September. There are also potential annual royalty revenues of up to £13m. Vectura still has plenty of opportunities to generate revenues from its IP because of the non-exclusivity of this deal. Telecoms test equipment supplier Spirent Communications has lost yesterday's share price gain following its interim figures. To put that into perspective, Spirent has risen by two-thirds in the past year. Spirent reported a 37% hike in first half pre-tax profit as demand picked up across its markets and said it is confident of building on momentum going into the second half. Pre-tax profit rose to $48.8m for the six months ended June 2010 compared to $35.5m a year earlier. Revenue increased to $227.2m from $208.7m while order intake rose 24%.Broker Panmure Gordon believes Spirent may buy back an increasing number of shares in the second half. FTSE TechMARK - RisersVectura Group (VEC) 55.25p +13.92%Wolfson Microelectronics (WLF) 200.00p +7.53%Logica (LOG) 116.20p +6.22%NXT (NTX) 9.38p +3.94%RM Group (RM.) 136.00p +3.82%Phoenix IT Group (PNX) 235.00p +3.52%CSR (CSR) 339.70p +1.74%Phytopharm (PYM) 8.13p +1.62%Filtronic (FTC) 39.00p +1.30%Torotrak (TRK) 22.75p +1.11%FTSE TechMARK - FallersRenovo Group (RNVO) 22.50p -5.26%Skyepharma (SKP) 38.00p -5.00%Puricore (PURI) 50.00p -4.76%Optos (OPTS) 100.00p -4.76%Spirent Communications (SPT) 128.10p -4.04%Sepura (SEPU) 43.25p -3.89%Consort Medical (CSRT) 380.00p -3.80%Parity Group (PTY) 7.25p -3.33%AEA Technology (AAT) 16.75p -2.90%BATM Advanced (BVC) 26.25p -2.78%